Synonyms: ARC-1905 | ARC1905 | Izervay® | Zimura
avacincaptad pegol is an approved drug (FDA (2023))
Compound class:
Synthetic organic
Comment: Avacincaptad pegol (ARC-1905) is a pegylated RNA aptamer that selectively binds to complement C5 and prevents its cleavage into C5a and C5b. This action inhibits activation of inflammasomes and the formation of membrane attack complexes (MAC). It is a clinical lead for age-related macular degeneration.
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2023)) |
International Nonproprietary Names | |
INN number | INN |
10099 | avacincaptad pegol |
Synonyms |
ARC-1905 | ARC1905 | Izervay® | Zimura |
Database Links | |
GtoPdb PubChem SID | 483123405 |
Search PubMed clinical trials | avacincaptad pegol |
Search PubMed titles | avacincaptad pegol |
Search PubMed titles/abstracts | avacincaptad pegol |